NVCR - Novocure initiates usability study for flexible torso array

Novocure (NVCR) announces that it has advanced a new, flexible torso array into a clinical usability study.The updated array will be tested by patients and their caregivers at four clinical sites in Europe.The new design is intended to improve skin adhesion, to increase degrees-of-motion, and potentially to reduce skin irritation.Novocure plans to conclude the usability study in the third quarter of 2021 and will identify the preferred regulatory pathway to bring the updated, flexible array to patients as soon as possible, the company said.

For further details see:

Novocure initiates usability study for flexible torso array